(Q66547172)
Statements
Phase II Study of Ramucirumab With Trastuzumab, Fluoropyrimidine, and Platinum in Patients With Metastatic HER2-Positive Gastroesophageal Junction and Gastric Cancer (English)
0 references
18 March 2016
0 references
26 February 2019
0 references
7
0 references
18 year
0 references